Phase I/II study of arterial infusion of 5-fluorouracil combined with systemic gemcitabine for unresectable pancreatic cancer
Phase 1
- Conditions
- nresectable pancreatic cancer
- Registration Number
- JPRN-UMIN000000573
- Lead Sponsor
- ara Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Not provided
Exclusion Criteria
1)distant metastaes except of liver and node 2)adequate drug distribution via celiac arterial infusion with alteration of pancreatic blood flow will not be achieved 3)Interstitial pneumonia in chest X-ray 4)active gastro-duodenal ulcer 5)Allergic reaction to iodine contrast material. 6)Infectious disease with fever over 38 degree Celcius or antibiotics required. 7)Pregnant or nursing. 8)Severe drug allergic reaction 9)The other severe complicated disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method